With so much at stake, there is no room for compromise. Edwards SAPIEN 3 TAVI helps you:

Deliver outcomes you demand


death or disabling stroke at 1 year in low risk patients1

Perfect the pathway through efficient procedures


of patients discharged the next day1*

Control for the future to continue to meet the emerging needs of new patient populations


successful post-TAVI coronary access3

*Study includes both SAPIEN XT and SAPIEN 3 valves.

The valve designed to meet your Higher Standard.

Scroll / swipe side to side to review timeline

*As defined in the PARTNER 3 Trial: valve related, procedure related, cardiac related rehospitilisation.1

These devices are not available for commercial supply in Australia and are shown for illustration purposes only.

Clinical Study


patients studied in Edwards clinical trials

Real world experience


patients treated worldwide with Edwards TAVI valves

Data on file at Edwards Lifesciences.

References:   1. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705. 2. Wood, D.A.; Lauck, S.B.; Cairns, J.A. et al. The Vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: The 3M TAVI Study. J Am Coll Cardiol Intv. 2019. 3. Tarantini G, Fovino LN, Le Prince P, et al. Coronary access and percutaneous coronary intervention up to 3 years after transcatheter aortic valve implantation with a balloon-expandable valve. Circ Cardiovasc Interv. 2020;13(7):e008972. 4. Leon MB, Smith CR, Mack MJ, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010 Oct 21;363(17):1597-607. 5. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374(17):1609-1620. 6. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380(18):1695-1705. 7. Nazif T, Daniels D, McCabe J, Chehab B, et al. Real-world experience with the SAPIEN 3 Ultra TAVI: A propensity matched analysis from the United States. Presented virtually at TVT Connect 2020.